These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 23564768)

  • 21. Comparison of two kinds of orthotopic xenograft models for human ovarian cancer.
    Zhu G; Hong L; Wang S; Junhong Cai ; Yang Z; Yao M
    Eur J Gynaecol Oncol; 2014; 35(6):724-7. PubMed ID: 25556281
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vascular endothelial growth factor c promotes ovarian carcinoma progression through paracrine and autocrine mechanisms.
    Decio A; Taraboletti G; Patton V; Alzani R; Perego P; Fruscio R; Jürgensmeier JM; Giavazzi R; Belotti D
    Am J Pathol; 2014 Apr; 184(4):1050-1061. PubMed ID: 24508126
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of expression of XIAP-associated factor 1 (XAF1) with clinicopathologic factors, overall survival, microvessel density and cisplatin-resistance in ovarian cancer.
    Wang Y; Mao H; Hao Q; Wang Y; Yang Y; Shen L; Huang S; Liu P
    Regul Pept; 2012 Oct; 178(1-3):36-42. PubMed ID: 22759793
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Wounding promotes ovarian cancer progression and decreases efficacy of cisplatin in a syngeneic mouse model.
    Lee Y; Kollara A; May T; Brown TJ
    J Ovarian Res; 2018 Jul; 11(1):56. PubMed ID: 29973223
    [TBL] [Abstract][Full Text] [Related]  

  • 25. FOXM1 confers to epithelial-mesenchymal transition, stemness and chemoresistance in epithelial ovarian carcinoma cells.
    Chiu WT; Huang YF; Tsai HY; Chen CC; Chang CH; Huang SC; Hsu KF; Chou CY
    Oncotarget; 2015 Feb; 6(4):2349-65. PubMed ID: 25537512
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of ascites volume on clinical outcomes in ovarian cancer: A cohort study.
    Szender JB; Emmons T; Belliotti S; Dickson D; Khan A; Morrell K; Khan ANMN; Singel KL; Mayor PC; Moysich KB; Odunsi K; Segal BH; Eng KH
    Gynecol Oncol; 2017 Sep; 146(3):491-497. PubMed ID: 28624153
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High level of CFTR expression is associated with tumor aggression and knockdown of CFTR suppresses proliferation of ovarian cancer in vitro and in vivo.
    Xu J; Yong M; Li J; Dong X; Yu T; Fu X; Hu L
    Oncol Rep; 2015 May; 33(5):2227-34. PubMed ID: 25738998
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relationship of tumor marker CA125 and ovarian tumor stem cells: preliminary identification.
    Zhang H; Yang Y; Wang Y; Gao X; Wang W; Liu H; He H; Liang Y; Pan K; Wu H; Shi J; Xue H; Liang L; Cai Z; Fan Y; Zhang Y
    J Ovarian Res; 2015 Mar; 8():19. PubMed ID: 25886959
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Overexpression of Siah2 Is Associated With Poor Prognosis in Patients With Epithelial Ovarian Carcinoma.
    Gao Y; Liu Y; Meng F; Shang P; Wang S; Zhang Y; Sun Y; Wang Y; Wang J; Chen X
    Int J Gynecol Cancer; 2016 Jan; 26(1):114-9. PubMed ID: 26512788
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of Transabdominal Ultrasound for the detection of intra-peritoneal tumor engraftment and growth in mouse xenografts of epithelial ovarian cancer.
    Chambers LM; Esakov E; Braley C; AlHilli M; Michener C; Reizes O
    PLoS One; 2020; 15(4):e0228511. PubMed ID: 32348309
    [TBL] [Abstract][Full Text] [Related]  

  • 31. LSR Antibody Therapy Inhibits Ovarian Epithelial Tumor Growth by Inhibiting Lipid Uptake.
    Hiramatsu K; Serada S; Enomoto T; Takahashi Y; Nakagawa S; Nojima S; Morimoto A; Matsuzaki S; Yokoyama T; Takahashi T; Fujimoto M; Takemori H; Ueda Y; Yoshino K; Morii E; Kimura T; Naka T
    Cancer Res; 2018 Jan; 78(2):516-527. PubMed ID: 29187404
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thymoquinone enhances cisplatin-response through direct tumor effects in a syngeneic mouse model of ovarian cancer.
    Wilson AJ; Saskowski J; Barham W; Yull F; Khabele D
    J Ovarian Res; 2015 Jul; 8():46. PubMed ID: 26215403
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cadherin composition and multicellular aggregate invasion in organotypic models of epithelial ovarian cancer intraperitoneal metastasis.
    Klymenko Y; Kim O; Loughran E; Yang J; Lombard R; Alber M; Stack MS
    Oncogene; 2017 Oct; 36(42):5840-5851. PubMed ID: 28628116
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Microenvironmental effects limit efficacy of thymoquinone treatment in a mouse model of ovarian cancer.
    Wilson AJ; Saskowski J; Barham W; Khabele D; Yull F
    Mol Cancer; 2015 Nov; 14():192. PubMed ID: 26552746
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Defective expression of Protein 4.1N is correlated to tumor progression, aggressive behaviors and chemotherapy resistance in epithelial ovarian cancer.
    Xi C; Ren C; Hu A; Lin J; Yao Q; Wang Y; Gao Z; An X; Liu C
    Gynecol Oncol; 2013 Dec; 131(3):764-71. PubMed ID: 23994105
    [TBL] [Abstract][Full Text] [Related]  

  • 36. c-Met inhibitors attenuate tumor growth of small cell hypercalcemic ovarian carcinoma (SCCOHT) populations.
    Otte A; Rauprich F; von der Ohe J; Yang Y; Kommoss F; Feuerhake F; Hillemanns P; Hass R
    Oncotarget; 2015 Oct; 6(31):31640-58. PubMed ID: 26436697
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of GLUT-1 in epithelial ovarian carcinoma: correlation with tumor cell proliferation, angiogenesis, survival and ability to predict optimal cytoreduction.
    Semaan A; Munkarah AR; Arabi H; Bandyopadhyay S; Seward S; Kumar S; Qazi A; Hussein Y; Morris RT; Ali-Fehmi R
    Gynecol Oncol; 2011 Apr; 121(1):181-6. PubMed ID: 21167567
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessment of False-negative Ascites Cytology in Epithelial Ovarian Carcinoma: A Study of 313 Patients.
    Allen VA; Takashima Y; Nayak S; Manahan KJ; Geisler JP
    Am J Clin Oncol; 2017 Apr; 40(2):175-177. PubMed ID: 25198110
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Highly and moderately aggressive mouse ovarian cancer cell lines exhibit differential gene expression.
    Du F; Li Y; Zhang W; Kale SP; McFerrin H; Davenport I; Wang G; Skripnikova E; Li XL; Bowen NJ; McDaniels LB; Meng YX; Polk P; Liu YY; Zhang QJ
    Tumour Biol; 2016 Aug; 37(8):11147-11162. PubMed ID: 26935058
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of adiponectin and its receptors is altered in epithelial ovarian tumors and ascites-derived ovarian cancer cell lines.
    Tiwari A; Ocon-Grove OM; Hadley JA; Giles JR; Johnson PA; Ramachandran R
    Int J Gynecol Cancer; 2015 Mar; 25(3):399-406. PubMed ID: 25700032
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.